This site is intended for health professionals only

Editor’s pick

Endo and European Orion collaborate in oncology
Endo and European Orion collaborate in oncology
Arthritis drug licence extended
Arthritis drug licence extended
Marketing authorisation for Rapiscan®
Marketing authorisation for Rapiscan®
Eisai submissions planned for first quarter
Eisai submissions planned for first quarter
Sanofi-aventis chooses OBT target cancer treatment
Sanofi-aventis chooses OBT target cancer treatment
CHMP positive opinion for breast cancer treatment
CHMP positive opinion for breast cancer treatment
Novartis to acquire Genoptix, Inc.
Novartis to acquire Genoptix, Inc.
Prazaxa® now approved in Japan
Prazaxa® now approved in Japan
Cancer Drugs Fund – a challenge and an opportunity
Cancer Drugs Fund – a challenge and an opportunity
New €250m facility will bring Geel workforce to 600
New €250m facility will bring Geel workforce to 600
BIA and NZBIO alliance formed
BIA and NZBIO alliance formed
EU-wide prescriptions
EU-wide prescriptions
1 … 27 28 29 30 31 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x